These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11479231)

  • 41. In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer.
    Israeli O; Goldring-Aviram A; Rienstein S; Ben-Baruch G; Korach J; Goldman B; Friedman E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):35-42. PubMed ID: 15949568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
    Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
    Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
    Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression.
    Peters DG; Kudla DM; Deloia JA; Chu TJ; Fairfull L; Edwards RP; Ferrell RE
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1717-23. PubMed ID: 16030107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.
    Bayani J; Brenton JD; Macgregor PF; Beheshti B; Albert M; Nallainathan D; Karaskova J; Rosen B; Murphy J; Laframboise S; Zanke B; Squire JA
    Cancer Res; 2002 Jun; 62(12):3466-76. PubMed ID: 12067990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronology and complexities of ovarian tumorigenesis in FORKO mice: age-dependent gene alterations and progressive dysregulation of Major Histocompatibility Complex (MHC) Class I and II profiles.
    Aravindakshan J; Chen XL; Sairam MR
    Mol Cell Endocrinol; 2010 Nov; 329(1-2):37-46. PubMed ID: 20615452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
    Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
    J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK.
    Fejzo MS; Ginther C; Dering J; Anderson L; Venkatesan N; Konecny G; Karlan B; Slamon DJ
    Genes Chromosomes Cancer; 2011 Jun; 50(6):434-41. PubMed ID: 21432940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between tumor size and stage in early versus advanced ovarian cancer.
    Horvath LE; Werner T; Boucher K; Jones K
    Med Hypotheses; 2013 May; 80(5):684-7. PubMed ID: 23474070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
    Schaner ME; Davidson B; Skrede M; Reich R; Flørenes VA; Risberg B; Berner A; Goldberg I; Givant-Horwitz V; Tropè CG; Kristensen GB; Nesland JM; Børresen-Dale AL
    Mol Cancer; 2005 Jul; 4():26. PubMed ID: 16042759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression signatures of TP53 mutations in serous ovarian cancers.
    Bernardini MQ; Baba T; Lee PS; Barnett JC; Sfakianos GP; Secord AA; Murphy SK; Iversen E; Marks JR; Berchuck A
    BMC Cancer; 2010 May; 10():237. PubMed ID: 20504346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression profiling reveals differentially expressed genes in ovarian cancer of the hen: support for oviductal origin?
    Treviño LS; Giles JR; Wang W; Urick ME; Johnson PA
    Horm Cancer; 2010 Aug; 1(4):177-86. PubMed ID: 21761365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional profiling develops molecular signatures for ovarian tumors.
    Smith DI
    Cytometry; 2002 Jan; 47(1):60-2. PubMed ID: 11774353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis.
    Simon R; Desper R; Papadimitriou CH; Peng A; Alberts DS; Taetle R; Trent JM; Schäffer AA
    Genes Chromosomes Cancer; 2000 May; 28(1):106-20. PubMed ID: 10738309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. microRNA and Ovarian Cancer.
    Langhe R
    Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatics analysis reveals potential candidate drugs for psychological stress in ovarian cancer.
    Sun N; Zang W; Li W
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1362-6. PubMed ID: 23104652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in gene expression and cellular architecture in an ovarian cancer progression model.
    Creekmore AL; Silkworth WT; Cimini D; Jensen RV; Roberts PC; Schmelz EM
    PLoS One; 2011 Mar; 6(3):e17676. PubMed ID: 21390237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microarray-based gene expression studies in ovarian cancer.
    Chon HS; Lancaster JM
    Cancer Control; 2011 Jan; 18(1):8-15. PubMed ID: 21273975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.